Clinical Trial

Momelotinib Effectiveness in Myelofibrosis

Name: Momelotinib Effectiveness in Myelofibrosis — clinical trial record (NCT07249606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Observational study aimed at evaluating the use of momelotinib in patients with primary or post polycythemia vera (PV) or post essential thrombocythemia myelofibrosis (post-ET MF) in a real-world setting.

Trial Details

NCT Number	NCT07249606
Lead Sponsor	Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions	Myelofibrosis (MF)
Enrollment	93 participants
Start Date	2026-01-02
Primary Completion	2028-01-02 (estimated)
Study Completion	2028-04-02 (estimated)
Updated on ClinicalTrials.gov	2025-11-25